Trade

Blue Jet Healthcare share price

High risk
  • 52%Low risk
  • 52%Moderate risk
  • 52%Balanced risk
  • 52%High risk
  • 52%Extreme risk
  • ₹422.00(1.30%)
    April 17, 2026 15:29:00 PM IST
    • NSE
    • BSE
  • Vol : 535.08 K (NSE + BSE)
    Last 20 day avg : 717.83 K

Blue Jet Healthcare is trading 1.30% upper at Rs 422.00 as compared to its last closing price. Blue Jet Healthcare has been trading in the price range of 430.35 & 417.50. Blue Jet Healthcare has given -21.40% in this year & 11.28% in the last 5 days. Blue Jet Healthcare has TTM P/E ratio 31.31 as compared to the sector P/E of 24.14.There are 6 analysts who have initiated coverage on Blue Jet Healthcare. There are 3 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 40.17 Crores in its last quarter.Listed peers of Blue Jet Healthcare include Torrent Pharmaceuticals (0.78%), Cipla (0.61%), Sun Pharmaceutical Industries (-1.06%).The Mutual Fund holding in Blue Jet Healthcare was at 1.62% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Blue Jet Healthcare was at 0.89% in 31 Mar 2026. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 18, 2026, 04:56 AM UTC

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.29
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.30
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
Price range
Day Range
Lowest
417.50
Highest
430.35
52 week range
Lowest
325.20
Highest
1,028.20
Blue Jet Healthcare News
Blue Jet Healthcare Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Torrent Pharmaceuticals
Bullish
4,188.950.781,41,699.2267.3217.10.8317.62
Cipla
Moderately Bearish
1,238.300.611,00,027.7322.953.870.870.81
Sun Pharmaceutical Industries
Bearish
1,675.20-1.064,01,927.1336.245.770.920.50
Divi's Laboratories
Neutral
6,230.60-1.061,65,415.9978.6111.520.460.01
Dr Reddy's Laboratories
Moderately Bearish
1,239.001.451,03,409.1618.633.140.632.34
Mutual Fund Ownership
View all
Samco Special Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 3.95
  • % of AUM 2.44
TrustMF Small Cap Fund Regular Growth
NA
  • Amount Invested (Cr.) 18.44
  • % of AUM 1.90
UTI Small Cap Fund Regular Growth
2/5
  • Amount Invested (Cr.) 45.80
  • % of AUM 1.01
WhiteOak Capital Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 1.88
  • % of AUM 0.56
Samco Multi Cap Fund Regular Growth
NA
  • Amount Invested (Cr.) 1.17
  • % of AUM 0.32
Blue Jet Healthcare Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-13Quarterly Results
2025-11-04Quarterly Results
2025-07-22Quarterly Results
2025-05-14Audited Results, Final Dividend & Others
2025-01-29Quarterly Results
About the company Blue Jet Healthcare
  • IndustryBiotechnology & Drugs
  • ISININE0KBH01020
  • BSE Code544009
  • NSE CodeBLUEJET
Blue Jet Healthcare Limited is an India-based company, specializing in manufacturing integrated contrast media, artificial sweeteners and its salts, as well as niche pharmaceutical intermediaries and active pharmaceutical ingredients (APIs). The Company serves as a business-to-business (B2B) company. Its integrated contrast media intermediate product categories include x-ray contrast media intermediates and MRI contrast media intermediates. Its x-ray contrast media intermediates include non-ionic APIs and ionic APIs. It manufactures saccharin and supplies to healthcare, pharma, animal feed, food and beverages industries globally. The Company's offerings include insoluble saccharin, saccharin sodium and insoluble saccharin. Its advance pharmaceutical intermediates and API products include Vanillic Acid, Docusate Sodium and TosMIC. It offers end-to-end integrated solutions from process development to commercialization of NCEs, advance intermediates, APIs and building blocks.
  • Management Info
  • Akshay AroraExecutive Chairman of the Board
  • Ganesh KaruppannanChief Financial Officer
  • Vimalendu SinghChief Operating Officer
  • Sweta PoddarCompliance Officer, Company Secretary
  • Shiven AroraManaging Director, Executive Director
  • Popat KedarExecutive Whole-Time Director
  • Naresh ShahExecutive Director
Blue Jet Healthcare Share Price FAQs

Blue Jet Healthcare is trading at 422.00 as on Fri Apr 17 2026 09:59:00. This is 1.30% upper as compared to its previous closing price of 416.60.

The market capitalization of Blue Jet Healthcare is 7320.24 Cr as on Fri Apr 17 2026 09:59:00.

The average broker rating on Blue Jet Healthcare is Buy. The breakup of analyst rating is given below -

  • 3 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Blue Jet Healthcare is 1028.20 whereas the 52 wk low is 325.20

Blue Jet Healthcare can be analyzed on the following key metrics -

  • TTM P/E: 31.31
  • Sector P/E: 24.14
  • Dividend Yield: 0.29%
  • D/E ratio: -

Blue Jet Healthcare reported a net profit of 305.20 Cr in 2025.

The Mutual Fund Shareholding was 1.62% at the end of 31 Mar 2026.

Quick Links
EQUITY QUICK LINKS
Blue Jet Healthcare QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Blue Jet Healthcare share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.